Safety and Immunogenicity of the DTP/HB /Hib Combination Vaccine: Phase I Study

Paediatrica Indonesiana
doi 10.14238/pi53.6.2013.309-14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Paediatrica Indonesiana - Indonesian Pediatric Society

Related search

The Safety of Haemophilus Influenzae Type B/Polyribosylribitol Phosphate-Tetanus (Hib/PRP-T) Vaccine, Phase I Study

International Journal of Integrated Health Sciences
2015English

Immunogenicity and Safety of a Combined DTPa-IPV/Hib Vaccine Administered as a Three-Dose Primary Vaccination Course in Healthy Korean Infants: Phase III, Randomized Study

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Feasibility Study of the Immunogenicity and Safety of a Novel DTPw/Hib (PRP-T) Brazilian Combination Compared to a Licensed Vaccine in Healthy Children at 2, 4, and 6 Months of Age

Revista da Sociedade Brasileira de Medicina Tropical
ParasitologyInfectious DiseasesMicrobiology
2003English

Construction and Phase I Clinical Evaluation of the Safety and Immunogenicity of a Candidate Enterotoxigenic Escherichia Coli Vaccine Strain Expressing Colonization Factor Antigen CFA/I

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2006English

A Randomized, Open-Label Clinical Trial to Evaluate Immunogenicity and Safety of an Indigenously Developed DTwP-Hib Tetravalent Combination Vaccine (Easyfour®-Tt) With Quadrovax® in Indian Infants

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2017English

Safety and Immunogenicity of a Live Attenuated Mumps Vaccine

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2014English

Safety and Immunogenicity of Hepatitis B Vaccine: A Study on Iranian Navy Personnel

Vaccine Research
2014English

Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3)

Epidemiology and Vaccine Prevention
2017English

Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy